Compounded Semaglutide And Antidepressants
Compounded semaglutide and antidepressants can be safely used together. The active ingredient in compounded semaglutide is identical to brand-name Ozempic and Wegovy, and no direct drug interactions exist between semaglutide and major antidepressant classes. Your prescribing physician should always review your complete medication list.
Compounded vs. Brand-Name: Same Interaction Profile
Some patients wonder whether compounded semaglutide behaves differently than brand-name versions when it comes to drug interactions. The answer is no. The semaglutide molecule is the same regardless of whether it comes from Novo Nordisk (as Ozempic or Wegovy) or from a 503A/503B compounding pharmacy.
Compounded formulations may differ in concentration (often supplied as multi-dose vials rather than pre-filled pens), inactive ingredients, and preservatives. None of these differences affect how semaglutide interacts with antidepressants or other medications.
Why Patients Choose Compounded Semaglutide
Cost is the primary driver. Brand-name Wegovy lists at over $1,300 per month without insurance, while compounded semaglutide through telehealth providers like Form Blends is typically a fraction of that price. For patients already managing the cost of antidepressant therapy (even with insurance), affordable GLP-1 access matters. $1,300-$1,400/mo (brand) From $299
Specific Antidepressant Compatibility
All major antidepressant classes are compatible with compounded semaglutide:
- SSRIs (sertraline, fluoxetine, escitalopram, citalopram, paroxetine): No interactions. Monitor for additive nausea during initiation of either drug.
- SNRIs (venlafaxine, duloxetine, desvenlafaxine): No interactions. Extended-release formulations are unaffected by gastric emptying delays.
- Bupropion: No interactions. May have complementary weight-loss effects.
- Tricyclics (amitriptyline, nortriptyline): No direct interactions, but these often cause weight gain and constipation. Discuss with your provider.
- MAOIs: No known interaction with semaglutide specifically, but MAOIs have complex dietary and drug interaction profiles that require careful physician oversight for any medication addition.
Communication Between Providers
If your antidepressant is prescribed by a psychiatrist and your compounded semaglutide by a different provider (such as Form Blends), make sure both clinicians are aware of your full medication list. This coordinated approach ensures:
- No medications are prescribed that could interact
- Side effects are attributed to the correct medication
- Dose adjustments account for all active treatments
- Your mental health is monitored during significant weight loss
Frequently Asked Questions
Can I take compounded semaglutide with my antidepressant?
Yes. Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy. Like all semaglutide products, it has no known direct interactions with antidepressants. Your provider should review your full medication list before prescribing.
Is compounded semaglutide different from brand-name regarding drug interactions?
No. The active molecule is identical. Compounded semaglutide interacts with other medications in the same way as Ozempic or Wegovy. The only differences are in concentration, inactive ingredients, and delivery device.
Should I tell my compounding pharmacy about my antidepressant?
Your prescribing physician handles drug interaction screening. The compounding pharmacy fills the prescription as written. However, it is always good practice to maintain a current medication list with every healthcare provider and pharmacy you use.
Will my antidepressant still work on compounded semaglutide?
Yes. Semaglutide does not reduce the effectiveness of antidepressants. The delayed gastric emptying effect may slightly slow absorption timing, but overall drug exposure and therapeutic levels remain unchanged for daily medications.
Affordable GLP-1 Therapy at Form Blends
Form Blends offers physician-supervised compounded semaglutide with full medication review. We make GLP-1 therapy accessible without compromising safety, even for patients on complex medication regimens.